在世界范围内大约20个实验中约1000例患者接受治疗，大多数使用骨髓干细胞或骨髓细胞衍生物来修复心脏病导致的损害。

Around 1000 patients have been treated in approximately 20 trials worldwide, mostly using bone marrow stem cells or derivatives of bone marrow cells to repair damage caused by heart attack.

youdao

目的探讨骨髓间充质干细胞复合骨生物衍生材料异位成骨的可行性和成骨能力。

Objective to investigate the ectopic osteogenesis potential of human natural bone derived material combined with human Mesenchymal Stem Cells.

youdao

目的探讨骨髓间充质干细胞复合骨生物衍生材料异位成骨的可行性和成骨能力。

Objective to investigate the ectopic osteogenesis potential of human natural bone derived material combined with human Mesenchymal Stem Cells.

youdao